176 related articles for article (PubMed ID: 23639297)
21. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
[TBL] [Abstract][Full Text] [Related]
22. Sex-specific differences in plasma levels of FXII, HK, and FXIIa-C1-esterase inhibitor complexes in community-acquired pneumonia.
Ehrlich K; Wilhelm J; Markart P; Weisser H; Wolff JC; Bein G; Pak O; Barreto G; Weissmann N; Schramm F; Seeger W; Schaefer L; Kuebler WM; Wygrecka M;
Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L764-L774. PubMed ID: 34318685
[TBL] [Abstract][Full Text] [Related]
23. FXII.
Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
Blut; 1990 Nov; 61(5):258-66. PubMed ID: 2271772
[TBL] [Abstract][Full Text] [Related]
24. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
Gallimore MJ; Harris SL; Jones DW; Winter M
Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
[TBL] [Abstract][Full Text] [Related]
26. Coagulation factor XII protease domain crystal structure.
Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
[TBL] [Abstract][Full Text] [Related]
27. An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma.
Ford RP; Esnouf MP; Burgess AI; Sarphie A
J Immunoassay; 1996 May; 17(2):119-31. PubMed ID: 8744282
[TBL] [Abstract][Full Text] [Related]
28. Competitive-protein adsorption in contact activation of blood factor XII.
Zhuo R; Siedlecki CA; Vogler EA
Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
[TBL] [Abstract][Full Text] [Related]
29. Factor XII does not initiate prekallikrein activation on endothelial cells.
Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
[TBL] [Abstract][Full Text] [Related]
30. The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome.
Harris SL; Jones DW; Gallimore MJ; Nicholls PJ; Winter M
J Thromb Haemost; 2005 May; 3(5):969-75. PubMed ID: 15869593
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to factor XII are distinct from antibodies to prothrombin in patients with the anti-phospholipid syndrome.
Jone DW; Nicholls PJ; Donohoe S; Gallimore MJ; Winter M
Thromb Haemost; 2002 Mar; 87(3):426-30. PubMed ID: 11916074
[TBL] [Abstract][Full Text] [Related]
32. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
Dors DM; Nuijens JH; Huijbregts CC; Hack CE
Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
[TBL] [Abstract][Full Text] [Related]
33. An in-house ELISA method for quantification of circulating tissue factor.
Tay SP; Cheong SK
Malays J Pathol; 2002 Jun; 24(1):45-51. PubMed ID: 16329555
[TBL] [Abstract][Full Text] [Related]
34. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock.
Wuillemin WA; Fijnvandraat K; Derkx BH; Peters M; Vreede W; ten Cate H; Hack CE
Thromb Haemost; 1995 Dec; 74(6):1436-41. PubMed ID: 8772216
[TBL] [Abstract][Full Text] [Related]
35. The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses.
Inomo A; Sugi T; Fujita Y; Matsubayashi H; Izumi S; Mikami M
Thromb Haemost; 2008 Feb; 99(2):316-23. PubMed ID: 18278180
[TBL] [Abstract][Full Text] [Related]
36. Quantitative double antibody sandwich ELISA for the determination of gliadin.
Gujral N; Suresh MR; Sunwoo HH
J Immunoassay Immunochem; 2012; 33(4):339-51. PubMed ID: 22963484
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to factor XII associated with lupus anticoagulant.
Jones DW; Gallimore MJ; Harris SL; Winter M
Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
[TBL] [Abstract][Full Text] [Related]
38. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
Declerck PJ; Van Keer L; Verstreken M; Collen D
Thromb Haemost; 1992 Jan; 67(1):95-100. PubMed ID: 1377417
[TBL] [Abstract][Full Text] [Related]
39. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
[TBL] [Abstract][Full Text] [Related]
40. Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces.
Konrath S; Mailer RK; Renné T
Hamostaseologie; 2021 Dec; 41(6):489-501. PubMed ID: 34592776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
